Location History:
- Milan, IT (1996)
- Meda, IT (1999 - 2013)
Company Filing History:
Years Active: 1996-2013
Title: Simona Sputore: Innovator in Cardiovascular Medicaments
Introduction
Simona Sputore is a prominent inventor based in Meda, Italy, known for her significant contributions to the field of medicinal chemistry. With a total of four patents to her name, she has focused her research on developing innovative compounds for the treatment of cardiovascular disorders. Her work has the potential to impact the lives of many patients suffering from heart-related conditions.
Latest Patents
One of her latest patents involves amino derivatives of androstanes and androstenes, which serve as medicaments for cardiovascular disorders. These compounds are particularly useful in treating heart failure and hypertension. They function as inhibitors of the enzymatic activity of the Na, K-ATPase, addressing diseases caused by the hypertensive effects of endogenous ouabain. This includes conditions such as renal failure progression in autosomal dominant polycystic renal disease (ADPKD), preeclamptic hypertension, and proteinuria. Another notable patent describes an improved process for the preparation of (E,Z) 3-(2-aminoethoxyimino)-androstane-6,17-dione and its analogues, enhancing the synthesis of these important compounds.
Career Highlights
Simona Sputore has made remarkable strides in her career, particularly through her work at Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. Her research has not only advanced the understanding of cardiovascular treatments but has also paved the way for new therapeutic options in the pharmaceutical industry.
Collaborations
Throughout her career, Simona has collaborated with esteemed colleagues such as Giulio Carzana and Marco Frigerio. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medicinal chemistry.
Conclusion
Simona Sputore's contributions to the development of cardiovascular medicaments highlight her role as a leading inventor in the pharmaceutical industry. Her innovative research continues to pave the way for advancements in treatment options for patients with cardiovascular disorders.